Hulbert Soh

Hulbert Soh joined Novo Holdings Asia in October 2022 as a Senior Associate.

Prior to joining Novo Holdings Asia, Hulbert was a Global Healthcare Investments Associate Director from SeaTown Holdings International (Subsidiary of Temasek Holdings). He also brings Healthcare investment experience from MyoKardia (Subsidiary of Bristol-Myers Squibb), Verily Life Sciences and Lazard Frères & Co. Hulbert started out at Credit Suisse as an Investment Banking Analyst, Biotechnolgy coverage.

Hulbert completed the Roy and Diana Vagelos Program in Life Sciences and Management (LSM) at University of Pennsylvania and holds a Bachelor of Art in Chemistry as well as a Bachelor of Science in Economics , Concentration in Finance from The Wharton School.